Bio-Rad Laboratories (BIO) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $26.39.
- Bio-Rad Laboratories' EPS (Weighted Average and Diluted) rose 20401.89% to $26.39 in Q4 2025 from the same period last year, while for Dec 2025 it was $27.65, marking a year-over-year increase of 14230.11%. This contributed to the annual value of $27.85 for FY2025, which is 14261.02% up from last year.
- Per Bio-Rad Laboratories' latest filing, its EPS (Weighted Average and Diluted) stood at $26.39 for Q4 2025, which was up 20401.89% from -$12.7 recorded in Q3 2025.
- In the past 5 years, Bio-Rad Laboratories' EPS (Weighted Average and Diluted) registered a high of $130.02 during Q3 2021, and its lowest value of -$112.5 during Q1 2022.
- Over the past 5 years, Bio-Rad Laboratories' median EPS (Weighted Average and Diluted) value was $2.98 (recorded in 2023), while the average stood at -$1.96.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first plummeted by 44658.04% in 2022, then surged by 54120.88% in 2024.
- Bio-Rad Laboratories' EPS (Weighted Average and Diluted) (Quarter) stood at -$51.82 in 2021, then skyrocketed by 153.64% to $27.79 in 2022, then crashed by 56.92% to $11.97 in 2023, then plummeted by 311.89% to -$25.37 in 2024, then soared by 204.02% to $26.39 in 2025.
- Its last three reported values are $26.39 in Q4 2025, -$12.7 for Q3 2025, and $11.52 during Q2 2025.